Gene · 5394
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A missense variant in EXOSC8 causes exon skipping and expands the phenotypic spectrum of pontocerebellar hypoplasia type 1C. | J Hum Genet | 2024 | 38017281 | PubTator, text mining | PubMed |
| Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course. | Arthritis Rheumatol | 2024 | 37488962 | PubTator, text mining | PubMed |
| Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies. | Rheumatology (Oxford) | 2024 | 37432378 | PubTator, text mining | PubMed |
| Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis. | Rheumatology (Oxford) | 2024 | 37158586 | PubTator, text mining | PubMed |
| Roles of ribosomal RNA in health and disease. | Front RNA Res | 2023 | 42212238 | PubTator, text mining | PubMed |
| Perspective to precision medicine in scleroderma. | Front Immunol | 2023 | 38304250 | PubTator, text mining | PubMed |
| Systemic Sclerosis with Inflammatory Myositis: A Case Report. | JNMA J Nepal Med Assoc | 2023 | 38289774 | PubTator, text mining | PubMed |
| Late Onset Systemic Lupus Erythematosus - Clinical and Autoantibody Profile and its Comparison with Young Onset Systemic Lupus Erythematosus. | Mediterr J Rheumatol | 2023 | 38282933 | PubTator, text mining | PubMed |
| Long Term Outcomes in Idiopathic Inflammatory Myositis: An Observational Epidemiologic Study over 15 Years. | Mediterr J Rheumatol | 2023 | 38282927 | PubTator, text mining | PubMed |
| A Challenging Inflammatory Myopathy Case-Report: Dermatomyositis-Like Rash in an Anti-HMGCR Positive Patient with an Uncertain Muscle Histology. | Mediterr J Rheumatol | 2023 | 38282924 | PubTator, text mining | PubMed |
| A Retrospective Study on Antinuclear Antibody Patterns in Systemic Lupus Erythematosus Patients and Its Correlation With Serological Markers. | Cureus | 2023 | 38186533 | PubTator, text mining | PubMed |
| Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients. | Front Med (Lausanne) | 2023 | 38179278 | PubTator, text mining | PubMed |
| Case report: Excessive daytime sleepiness as a presenting manifestation of autoimmune glial fibrillary acidic protein astrocytopathy. | Front Immunol | 2023 | 38173730 | PubTator, text mining | PubMed |
| Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes. | Immun Inflamm Dis | 2023 | 38134320 | PubTator, text mining | PubMed |
| Effect of serum autoantibodies on the COVID-19 patient's prognosis. | Front Microbiol | 2023 | 38107861 | PubTator, text mining | PubMed |
| Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study. | Front Immunol | 2023 | 38098481 | PubTator, text mining | PubMed |
| Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. | Acta Neuropathol Commun | 2023 | 38066589 | PubTator, text mining | PubMed |
| Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. | Nat Genet | 2023 | 38049665 | PubTator, text mining | PubMed |
| Necrotizing Autoimmune Myopathy: A Case Report on Statin-Induced Rhabdomyolysis. | Cureus | 2023 | 38024077 | PubTator, text mining | PubMed |
The Role of Indirect Immunofluorescence (IIF) and Line Immunoassay (LIA) in the Diagnosis of Autoimmune Diseases and Their Clinical Correlation: An Observational Study From a Tertiary Care Center in Bihar. | Cureus | 2023 | 38022160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5394/papers?page=4